News

Biomednewsbreaks - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Appoints Eric Poma As CEO To Lead Next Phase Of Clinical Growth
Calidi Biotherapeutics (NYSE American: CLDI) announced the appointment of Eric Poma, Ph.D., as Chief Executive Officer and member of its Board of Di ...